RP-5063(Brilaroxazine) is a multimodal modulator of serotonin and dopamine receptors that helps stabilize the serotonin/dopamine system, a key determinant of the pathogenesis of schizophrenia and other associated neuropsychiatric disorders. Brilaroxazine exhibits high binding affinity for the D2, D3, D4, 5-HT1A, 5-HT2A, 5-HT2B and 5-HT7 receptors (Ki, ≤6 nM), and moderate binding affinity for the serotonin transporter (SERT), 5-HT6 receptor, and the nicotinic acetylcholine receptor α4β2 (Ki, ≤50 nM).
For research use only. We do not sell to patients.
Name | RP-5063(Brilaroxazine) |
---|---|
Iupac Chemical Name | 6-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one |
Synonyms | RP-5063 ; Brilaroxazine ; RP5063 ; RP 5063 |
Molecular Formula | C22H25Cl2N3O3 |
Molecular Weight | 450.36 |
Smile | ClC1=C(N2CCN(CCCCOC3=CC=C(OCC(N4)=O)C4=C3)CC2)C=CC=C1Cl |
InChiKey | PMKMNTBZJOXTJW-UHFFFAOYSA-N |
InChi | InChI=1S/C22H25Cl2N3O3/c23-17-4-3-5-19(22(17)24)27-11-9-26(10-12-27)8-1-2-13-29-16-6-7-20-18(14-16)25-21(28)15-30-20/h3-7,14H,1-2,8-13,15H2,(H,25,28) |
CAS Number | 1239729-06-6 |
Related CAS | 1239729-06-6 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |